Related Experiment Video
Updated: Jun 13, 2026

Biosensor for Detection of Antibiotic Resistant Staphylococcus Bacteria
Published on: May 8, 2013
Lack of increase in vancomycin resistance of pediatric methicillin-resistant Staphylococcus aureus Isolates from 2000
Xiaotian Zheng1, Chao Qi, Mollyn Arrieta
1Department of Pathology and Laboratory Medicine, Children's Memorial Hospital, Chicago, IL, USA. x-zheng@northwestern.edu
Abstract:
We retrospectively studied 306 pediatric methicillin-resistant Staphylococcus aureus isolates collected in 2000/2001, 2003, 2005, and 2007 for possible vancomycin minimum inhibitory concentration (MIC) change over time using Etest, agar dilution, and broth microdilution (MicroScan) methods. Vancomycin MICs did not increase. Inducible clindamycin resistance declined significantly (53%-0%, P < 0.001). Considerably different proportions of isolates with vancomycin MIC = 2 microg/mL were identified by different laboratory methodologies, suggesting the need for caution in their interpretation and in comparing published data. During this period the proportion of USA300 strains increased dramatically.
Insights
Methicillin-resistant Staphylococcus aureus (MRSA) vancomycin MICs in children did not increase. Inducible clindamycin resistance declined, but USA300 strain prevalence rose. Laboratory methods varied in vancomycin MIC results.
Area of Science:
- Microbiology
- Infectious Diseases
- Clinical Laboratory Science
Background:
- Pediatric methicillin-resistant Staphylococcus aureus (MRSA) poses a significant public health challenge.
- Monitoring antimicrobial resistance trends, particularly to vancomycin, is crucial for effective treatment strategies.
- Previous studies have indicated potential shifts in MRSA characteristics over time.
Purpose of the Study:
- To investigate changes in vancomycin minimum inhibitory concentration (MIC) of pediatric MRSA isolates over an eight-year period.
- To assess trends in inducible clindamycin resistance and the prevalence of the USA300 strain.
- To compare the performance of different laboratory methodologies in determining vancomycin MICs.
Main Methods:
- Retrospective analysis of 306 pediatric MRSA isolates collected between 2000 and 2007.
- Determination of vancomycin MICs using Etest, agar dilution, and broth microdilution (MicroScan).
- Evaluation of inducible clindamycin resistance and identification of MRSA strain types (e.g., USA300).
Main Results:
- No significant increase in vancomycin MICs was observed over the study period.
- A dramatic decline in inducible clindamycin resistance was noted, from 53% to 0% (P < 0.001).
- Significant variations in the proportion of isolates with vancomycin MIC = 2 microg/mL were detected across different laboratory methods.
- The prevalence of the USA300 MRSA strain increased substantially during this timeframe.
Conclusions:
- Vancomycin susceptibility in pediatric MRSA isolates remained stable during 2000-2007.
- The decline in inducible clindamycin resistance suggests a potential shift in resistance mechanisms or strain characteristics.
- Discrepancies in vancomycin MIC results among laboratory methods highlight the need for careful interpretation and standardization.
- The rise of the USA300 strain warrants continued surveillance due to its association with community-acquired infections.
Related Concept Videos
Mechanism of Antibiotic Resistance in MRSA
Clinical Significance of Antibiotic Resistance
Development of Antibiotic Resistance
Pharmacokinetics in Pediatric Patients: Drug Excretion
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Antimicrobial Effectiveness